Antidepressants To Add Class Labeling On Pregnancy & Serotonin Syndrome

Antidepressants remain at the forefront of FDA's safety focus with a pair of public health advisories on use during pregnancy and on concomitant use with triptans

More from Archive

More from Pink Sheet